141 related articles for article (PubMed ID: 16147848)
1. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation.
Muy-Rivera M; Sanchez SE; Vadachkoria S; Qiu C; Bazul V; Williams MA
Am J Hypertens; 2004 Apr; 17(4):334-8. PubMed ID: 15062887
[TBL] [Abstract][Full Text] [Related]
3. Elevated soluble vascular cell adhesion molecule-1, elevated Homocyst(e)inemia, and hypertriglyceridemia in relation to preeclampsia risk.
Vadachkoria S; Woelk GB; Mahomed K; Qiu C; Muy-Rivera M; Malinow MR; Williams MA
Am J Hypertens; 2006 Mar; 19(3):235-42. PubMed ID: 16500507
[TBL] [Abstract][Full Text] [Related]
4. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women.
Williams MA; Mahomed K; Farrand A; Woelk GB; Mudzamiri S; Madzime S; King IB; McDonald GB
J Reprod Immunol; 1998 Nov; 40(2):159-73. PubMed ID: 9881743
[TBL] [Abstract][Full Text] [Related]
5. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?
Clausen T; Djurovic S; Reseland JE; Berg K; Drevon CA; Henriksen T
Placenta; 2002 May; 23(5):380-5. PubMed ID: 12061853
[TBL] [Abstract][Full Text] [Related]
6. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA
Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte selenium, zinc, and copper concentrations in preeclamptic and normotensive pregnant women.
Mahomed K; Williams MA; Woelk GB; Mudzamiri S; Madzime S; King IB; Bankson DD
Biol Trace Elem Res; 2000; 75(1-3):107-18. PubMed ID: 11051601
[TBL] [Abstract][Full Text] [Related]
8. Relationship of maternal plasma leptin and risk of pre-eclampsia: a prospective study.
Ning Y; Williams MA; Muy-Rivera M; Leisenring WM; Luthy DA
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):186-92. PubMed ID: 15280145
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.
Peraçoli MT; Menegon FT; Borges VT; de Araújo Costa RA; Thomazini-Santos IA; Peraçoli JC
J Reprod Immunol; 2008 Oct; 79(1):79-84. PubMed ID: 18805591
[TBL] [Abstract][Full Text] [Related]
10. A case-control study of oxidized low density lipoproteins and preeclampsia risk.
Sanchez SE; Williams MA; Muy-Rivera M; Qiu C; Vadachkoria S; Bazul V
Gynecol Endocrinol; 2005 Oct; 21(4):193-9. PubMed ID: 16316839
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for preeclampsia-eclampsia among Zimbabwean women: recurrence risk and familial tendency towards hypertension.
Mahomed K; Williams MA; Woelk GB; Jenkins-Woelk L; Mudzamiri S; Madzime S; Sorensen TK
J Obstet Gynaecol; 1998 May; 18(3):218-22. PubMed ID: 15512062
[TBL] [Abstract][Full Text] [Related]
12. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia.
Naicker T; Khedun SM; Moodley J
J Obstet Gynaecol; 2002 May; 22(3):279-82. PubMed ID: 12521499
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta-1 influence on fetal allografts during pregnancy.
Ayatollahi M; Geramizadeh B; Samsami A
Transplant Proc; 2005 Dec; 37(10):4603-4. PubMed ID: 16387180
[TBL] [Abstract][Full Text] [Related]
16. Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia.
Ning Y; Williams MA; Vadachkoria S; Muy-Rivera M; Frederick IO; Luthy DA
Clin Biochem; 2004 Nov; 37(11):968-73. PubMed ID: 15498523
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C and preeclampsia: a case control study.
Franceschini N; Qiu C; Barrow DA; Williams MA
Ren Fail; 2008; 30(1):89-95. PubMed ID: 18197549
[TBL] [Abstract][Full Text] [Related]
18. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
[TBL] [Abstract][Full Text] [Related]
19. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Aderka D; Wallach D; Socol ML
Obstet Gynecol; 1996 Sep; 88(3):420-7. PubMed ID: 8752252
[TBL] [Abstract][Full Text] [Related]
20. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
